Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus

References

• Farazi A, Zarrinfar N, Didgar F, et al. Risk factors for failure of treatment and relapse of brucellosis. Arak Uni Med Sci. 2014;17(4):47–53.
   Google Scholar
• Díaz R, Gamazo C. Protective effect of liposomal gentamicin against systemic acute murine brucellosis. Chemotherapy 1997;43:204–210.
   PubMed Web of Science ®Google Scholar
• de Figueiredo P, Ficht TA, Rice-Ficht A, et al. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol. 2015;185:1505–1517.
   PubMed Web of Science ®Google Scholar
• Seleem MN, Jain N, Pothayee N, et al. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline. FEMS Microbiol Lett. 2009;294:24–31.
   PubMed Web of Science ®Google Scholar
• Roushan MRH, Moulana Z, Afshar ZM, et al. Risk factors for relapse of human brucellosis. Global J Health Sci. 2016;8:77.
   Google Scholar
• Imbuluzqueta E, Gamazo C, Ariza J, et al. Drug delivery systems for potential treatment of intracellular bacterial infections. Front Biosci. 2010;65:1215–1223.
   Google Scholar
• Kunjachan S, Jose S, Thomas CA, et al. Physicochemical and biological aspects of macrophage‐mediated drug targeting in anti‐microbial therapy. Fundam Clin Pharmacol. 2012;26:63–71.
   PubMed Web of Science ®Google Scholar
• Briones E, Colino CI, Lanao JM. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release. 2008;125:210–227.
   PubMed Web of Science ®Google Scholar
• Farnia P, Velayati AA, Mollaei S, et al. Modified rifampin nanoparticles: increased solubility with slow release rate. Int J Mycobacteriol. 2017;6:171.
   PubMed Web of Science ®Google Scholar
• Gelperina S, Kisich K, Iseman MD, et al. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 2005;172:1487–1490.
   PubMed Web of Science ®Google Scholar
• Lopes CPA. Development and characterization of lipid nanoparticles prepared by miniemulsion technique [dissertation]. Portugal: Technico Lisboa; 2014.
   Google Scholar
• Pei Y, Yeo Y. Drug delivery to macrophages: challenges and opportunities. J Control Release. 2016;240:202–211.
   PubMed Web of Science ®Google Scholar
• Ekambaram P, Sathali AAH, Priyanka K. Solid lipid nanoparticles: a review. Sci Rev Chem Commun. 2012;2:80–102.
   Web of Science ®Google Scholar
• Xiong M-H, Bao Y, Yang X-Z, et al. Delivery of antibiotics with polymeric particles. Adv Drug Deliv Rev. 2014;78:63–76.
   PubMed Web of Science ®Google Scholar
• Kharaji MH, Doroud D, Taheri T, et al. Drug targeting to macrophages with solid lipid nanoparticles harboring paromomycin: an in vitro evaluation against L. major and L. tropica. AAPS PharmSciTech. 2016;17:1110–1119.
   PubMed Web of Science ®Google Scholar
• Kalhapure RS, Mocktar C, Sikwal DR, et al. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles. Coll Surf B Biointer. 2014;117:303–311.
   PubMed Web of Science ®Google Scholar
• Vitthal KU, Pillai M, Kininge P. Study of solid lipid nanoparticles as a carrier for bacoside. Int J Pharma BioSci. 2013;3:414–426.
   Google Scholar
• Ekambaram P, Sathali A. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm. 2011;3:216–220.
   PubMedGoogle Scholar
• Kumar M, Kakkar V, Mishra AK, et al. Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood. Int J Pharm. 2014;461:223–233.
   PubMed Web of Science ®Google Scholar
• Li M, Zahi MR, Yuan Q, et al. Preparation and stability of astaxanthin solid lipid nanoparticles based on stearic acid. Eur J Lipid Sci Technol. 2016;118:592–602.
   Web of Science ®Google Scholar
• Siddiqui A, Alayoubi A, El-Malah Y, et al. Modeling the effect of sonication parameters on size and dispersion temperature of solid lipid nanoparticles (SLNs) by response surface methodology (RSM). Pharm Dev Technol. 2014;19:342–346.
   PubMed Web of Science ®Google Scholar
• Sivadasan D, Madavan B, Penmatsa SD, et al. Formulation and characterization of solid lipid nanoparticles of rifampicin. Erciyes Med J. 2012;35:1–5.
   Google Scholar
• Pandey R, Sharma S, Khuller G. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis. 2005;85:415–420.
   PubMed Web of Science ®Google Scholar
• Xu XM, Wang YS, Chen RY, et al. Formulation and pharmacokinetic evaluation of tetracycline-loaded solid lipid nanoparticles for subcutaneous injection in mice. Chem Pharm Bull. 2011;59:260–265.
   PubMed Web of Science ®Google Scholar
• Singh H, Bhandari R, Kaur IP. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH. Int J Pharm. 2013;446:106–111.
   PubMed Web of Science ®Google Scholar
• Lim WH, Tan YJ, Lee CS, et al. Preparation and optimization of palm-based lipid nanoparticles loaded with griseofulvin. Iran J Pharm Res. 2017;16:451.
   PubMed Web of Science ®Google Scholar
• Aboutaleb E, Noori M, Gandomi N, et al. Improved antimycobacterial activity of rifampin using solid lipid nanoparticles. Int Nano Lett. 2012;2:33.
   Google Scholar
• Kakkar V, Kaur IP. Preparation, characterization and scale-up of sesamol loaded solid lipid nanoparticles. Nanotechnol Dev. 2012;2:8.
   Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2012;64:83–101.
   Web of Science ®Google Scholar
• Kazemi D, Salouti M, Rostamizadeh K, et al. Development of gentamicin-loaded solid lipid nanoparticles: evaluation of drug release kinetic and antibacterial activity against Staphylococcus aureus. Int J Pharm Res Innov. 2014;7:1–6.
   Google Scholar
• Ghaffari S, Varshosaz J, Saadat A, et al. Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. Int J Nanomed. 2011;6:35.
   Web of Science ®Google Scholar
• Jain D, Banerjee R. Comparison of ciprofloxacin hydrochloride‐loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res. 2008;86:105–112.
   Web of Science ®Google Scholar
• Hu F-Q, Jiang S-P, Du Y-Z, et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Coll Surf B: Biointer. 2005;45:167–173.
   PubMed Web of Science ®Google Scholar
• Nikam S, Chavan M, Sharma PH. Solid lipid nanoparticles: a lipid based drug delivery. Nanotechnology. 2014;1:5.
   Google Scholar
• Gupta S, Kesarla R, Chotai N, et al. Systematic approach for the formulation and optimization of solid lipid nanoparticles of efavirenz by high pressure homogenization using design of experiments for brain targeting and enhanced bioavailability. BioMed Res Int. 2017;2017:1.
   Web of Science ®Google Scholar
• Lalan M, Baweja J, Misra A. Atopic dermatitis: drug delivery approaches in disease management. Crit Rev Ther Drug Carr Syst. 2015;32:323–361.
   PubMed Web of Science ®Google Scholar
• Wang R, Li L, Wang B, et al. FK506-loaded solid lipid nanoparticles: preparation, characterization and in vitro transdermal drug delivery. Afr J Pharm Pharmacol. 2012;6:904–913.
   Web of Science ®Google Scholar
• Sharma HS, Sharma A. Conference scene: nanoneuroprotection and nanoneurotoxicity: recent progress and future perspectives. Nanomedicine 2010;5:533–537.
   PubMed Web of Science ®Google Scholar
• Hippalgaonkar K, Majumdar S, Kansara V. Injectable lipid emulsions—advancements, opportunities and challenges. AAPS PharmSciTech. 2010;11:1526–1540.
   PubMed Web of Science ®Google Scholar
• Tan ME, He CH, Jiang W, et al. Development of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia–reperfusion injury in rats. Int J Nanomed. 2017;12:3253.
   PubMed Web of Science ®Google Scholar
• Singh H, Jindal S, Singh M, et al. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety. Int J Pharm. 2015;485:138–151.
   PubMed Web of Science ®Google Scholar
• Wissing S, Müller R. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm. 2002;242:377–379.
   PubMed Web of Science ®Google Scholar
• Singh RP, Gangadharappa H, Mruthunjaya K. Phospholipids: unique carriers for drug delivery systems. J Drug Deliv Sci Technol. 2017;39:166–179.
   Web of Science ®Google Scholar
• Du Y, Zhai Y, Zhang J, et al. Development and evaluation of taste-masked dry suspension of cefuroxime axetil for enhancement of oral bioavailability. Asian J Pharm Sci. 2013;8:287–294.
   Google Scholar
• Severino P, Pinho SC, Souto EB, et al. Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles. Coll Surf B Biointer. 2011;86:125–130.
   PubMed Web of Science ®Google Scholar
• Chen D-B, Yang T-Z, Lu W-L, et al. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull. 2001;49:1444–1447.
   PubMed Web of Science ®Google Scholar
• Ebrahimi HA, Javadzadeh Y, Hamidi M, et al. Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles. DARU J Pharm Sci. 2015;23:46.
   Web of Science ®Google Scholar
• Bibi S, Bremner DH, Macdougall-Heasman M, et al. A preliminary investigation to group disparate batches of licit and illicit diazepam tablets using differential scanning calorimetry. Anal Methods. 2015;7:8597–8604.
   Web of Science ®Google Scholar
• Vieira AC, Magalhães J, Rocha S, et al. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment. Nanomedicine 2017;12:2721–2736.
   PubMed Web of Science ®Google Scholar
• Bodaghabadi N, Hajigholami S, Malekshahi ZV, et al. Preparation and evaluation of rifampicin and co-trimoxazole-loaded nanocarrier against Brucella melitensis infection. Iran Biomed J. 2018;22:275.
   PubMedGoogle Scholar